Global Antiemetics Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Antiemetics market report explains the definition, types, applications, major countries, and major players of the Antiemetics market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GlaxoSmithKline

    • Sanofi Aventis

    • Astellas

    • Pfizer

    • Merck

    • Bristol Myers Squibb

    • Eli Lilly

    • Baxter

    • Johnson & Johnson

    By Type:

    • 5-HT3 receptor antagonists

    • Dopamine antagonists

    • NK1 receptor antagonist

    • Antihistamines (H1 histamine receptor antagonists)

    • Cannabinoids

    • Benzodiazepines

    • Anticholinergics

    • Steroids

    • Others

    By End-User:

    • Chemotherapy

    • Motion sickness

    • Gastroenteritis

    • General anesthetics

    • Opioid analgesics

    • Dizziness

    • Pregnancy

    • Food poisoning

    • Emotional stress

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Antiemetics Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Antiemetics Outlook to 2028- Original Forecasts

    • 2.2 Antiemetics Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Antiemetics Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Antiemetics Market- Recent Developments

    • 6.1 Antiemetics Market News and Developments

    • 6.2 Antiemetics Market Deals Landscape

    7 Antiemetics Raw Materials and Cost Structure Analysis

    • 7.1 Antiemetics Key Raw Materials

    • 7.2 Antiemetics Price Trend of Key Raw Materials

    • 7.3 Antiemetics Key Suppliers of Raw Materials

    • 7.4 Antiemetics Market Concentration Rate of Raw Materials

    • 7.5 Antiemetics Cost Structure Analysis

      • 7.5.1 Antiemetics Raw Materials Analysis

      • 7.5.2 Antiemetics Labor Cost Analysis

      • 7.5.3 Antiemetics Manufacturing Expenses Analysis

    8 Global Antiemetics Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Antiemetics Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Antiemetics Export by Region (Top 10 Countries) (2017-2028)

    9 Global Antiemetics Market Outlook by Types and Applications to 2022

    • 9.1 Global Antiemetics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 5-HT3 receptor antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dopamine antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global NK1 receptor antagonist Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Antihistamines (H1 histamine receptor antagonists) Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Cannabinoids Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Benzodiazepines Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Anticholinergics Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Steroids Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antiemetics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Motion sickness Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastroenteritis Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global General anesthetics Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Opioid analgesics Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Dizziness Consumption and Growth Rate (2017-2022)

      • 9.2.7 Global Pregnancy Consumption and Growth Rate (2017-2022)

      • 9.2.8 Global Food poisoning Consumption and Growth Rate (2017-2022)

      • 9.2.9 Global Emotional stress Consumption and Growth Rate (2017-2022)

      • 9.2.10 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Antiemetics Market Analysis and Outlook till 2022

    • 10.1 Global Antiemetics Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Antiemetics Consumption (2017-2022)

      • 10.2.2 Canada Antiemetics Consumption (2017-2022)

      • 10.2.3 Mexico Antiemetics Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Antiemetics Consumption (2017-2022)

      • 10.3.2 UK Antiemetics Consumption (2017-2022)

      • 10.3.3 Spain Antiemetics Consumption (2017-2022)

      • 10.3.4 Belgium Antiemetics Consumption (2017-2022)

      • 10.3.5 France Antiemetics Consumption (2017-2022)

      • 10.3.6 Italy Antiemetics Consumption (2017-2022)

      • 10.3.7 Denmark Antiemetics Consumption (2017-2022)

      • 10.3.8 Finland Antiemetics Consumption (2017-2022)

      • 10.3.9 Norway Antiemetics Consumption (2017-2022)

      • 10.3.10 Sweden Antiemetics Consumption (2017-2022)

      • 10.3.11 Poland Antiemetics Consumption (2017-2022)

      • 10.3.12 Russia Antiemetics Consumption (2017-2022)

      • 10.3.13 Turkey Antiemetics Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Antiemetics Consumption (2017-2022)

      • 10.4.2 Japan Antiemetics Consumption (2017-2022)

      • 10.4.3 India Antiemetics Consumption (2017-2022)

      • 10.4.4 South Korea Antiemetics Consumption (2017-2022)

      • 10.4.5 Pakistan Antiemetics Consumption (2017-2022)

      • 10.4.6 Bangladesh Antiemetics Consumption (2017-2022)

      • 10.4.7 Indonesia Antiemetics Consumption (2017-2022)

      • 10.4.8 Thailand Antiemetics Consumption (2017-2022)

      • 10.4.9 Singapore Antiemetics Consumption (2017-2022)

      • 10.4.10 Malaysia Antiemetics Consumption (2017-2022)

      • 10.4.11 Philippines Antiemetics Consumption (2017-2022)

      • 10.4.12 Vietnam Antiemetics Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Antiemetics Consumption (2017-2022)

      • 10.5.2 Colombia Antiemetics Consumption (2017-2022)

      • 10.5.3 Chile Antiemetics Consumption (2017-2022)

      • 10.5.4 Argentina Antiemetics Consumption (2017-2022)

      • 10.5.5 Venezuela Antiemetics Consumption (2017-2022)

      • 10.5.6 Peru Antiemetics Consumption (2017-2022)

      • 10.5.7 Puerto Rico Antiemetics Consumption (2017-2022)

      • 10.5.8 Ecuador Antiemetics Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Antiemetics Consumption (2017-2022)

      • 10.6.2 Kuwait Antiemetics Consumption (2017-2022)

      • 10.6.3 Oman Antiemetics Consumption (2017-2022)

      • 10.6.4 Qatar Antiemetics Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Antiemetics Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Antiemetics Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Antiemetics Consumption (2017-2022)

      • 10.7.2 South Africa Antiemetics Consumption (2017-2022)

      • 10.7.3 Egypt Antiemetics Consumption (2017-2022)

      • 10.7.4 Algeria Antiemetics Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Antiemetics Consumption (2017-2022)

      • 10.8.2 New Zealand Antiemetics Consumption (2017-2022)

    11 Global Antiemetics Competitive Analysis

    • 11.1 GlaxoSmithKline

      • 11.1.1 GlaxoSmithKline Company Details

      • 11.1.2 GlaxoSmithKline Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GlaxoSmithKline Antiemetics Main Business and Markets Served

      • 11.1.4 GlaxoSmithKline Antiemetics Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi Aventis

      • 11.2.1 Sanofi Aventis Company Details

      • 11.2.2 Sanofi Aventis Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi Aventis Antiemetics Main Business and Markets Served

      • 11.2.4 Sanofi Aventis Antiemetics Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Astellas

      • 11.3.1 Astellas Company Details

      • 11.3.2 Astellas Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Astellas Antiemetics Main Business and Markets Served

      • 11.3.4 Astellas Antiemetics Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Details

      • 11.4.2 Pfizer Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Pfizer Antiemetics Main Business and Markets Served

      • 11.4.4 Pfizer Antiemetics Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Merck

      • 11.5.1 Merck Company Details

      • 11.5.2 Merck Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Merck Antiemetics Main Business and Markets Served

      • 11.5.4 Merck Antiemetics Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Bristol Myers Squibb

      • 11.6.1 Bristol Myers Squibb Company Details

      • 11.6.2 Bristol Myers Squibb Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Bristol Myers Squibb Antiemetics Main Business and Markets Served

      • 11.6.4 Bristol Myers Squibb Antiemetics Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Eli Lilly

      • 11.7.1 Eli Lilly Company Details

      • 11.7.2 Eli Lilly Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Eli Lilly Antiemetics Main Business and Markets Served

      • 11.7.4 Eli Lilly Antiemetics Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Baxter

      • 11.8.1 Baxter Company Details

      • 11.8.2 Baxter Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Baxter Antiemetics Main Business and Markets Served

      • 11.8.4 Baxter Antiemetics Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Johnson & Johnson

      • 11.9.1 Johnson & Johnson Company Details

      • 11.9.2 Johnson & Johnson Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Johnson & Johnson Antiemetics Main Business and Markets Served

      • 11.9.4 Johnson & Johnson Antiemetics Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    12 Global Antiemetics Market Outlook by Types and Applications to 2028

    • 12.1 Global Antiemetics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 5-HT3 receptor antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Dopamine antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global NK1 receptor antagonist Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Antihistamines (H1 histamine receptor antagonists) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Cannabinoids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Benzodiazepines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Steroids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Antiemetics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Motion sickness Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global General anesthetics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Opioid analgesics Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Dizziness Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.7 Global Pregnancy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.8 Global Food poisoning Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.9 Global Emotional stress Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.10 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Antiemetics Market Analysis and Outlook to 2028

    • 13.1 Global Antiemetics Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Antiemetics Consumption Forecast (2022-2028)

      • 13.2.2 Canada Antiemetics Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Antiemetics Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Antiemetics Consumption Forecast (2022-2028)

      • 13.3.2 UK Antiemetics Consumption Forecast (2022-2028)

      • 13.3.3 Spain Antiemetics Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Antiemetics Consumption Forecast (2022-2028)

      • 13.3.5 France Antiemetics Consumption Forecast (2022-2028)

      • 13.3.6 Italy Antiemetics Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Antiemetics Consumption Forecast (2022-2028)

      • 13.3.8 Finland Antiemetics Consumption Forecast (2022-2028)

      • 13.3.9 Norway Antiemetics Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Antiemetics Consumption Forecast (2022-2028)

      • 13.3.11 Poland Antiemetics Consumption Forecast (2022-2028)

      • 13.3.12 Russia Antiemetics Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Antiemetics Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Antiemetics Consumption Forecast (2022-2028)

      • 13.4.2 Japan Antiemetics Consumption Forecast (2022-2028)

      • 13.4.3 India Antiemetics Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Antiemetics Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Antiemetics Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Antiemetics Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Antiemetics Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Antiemetics Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Antiemetics Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Antiemetics Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Antiemetics Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Antiemetics Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Antiemetics Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Antiemetics Consumption Forecast (2022-2028)

      • 13.5.3 Chile Antiemetics Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Antiemetics Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Antiemetics Consumption Forecast (2022-2028)

      • 13.5.6 Peru Antiemetics Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Antiemetics Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Antiemetics Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Antiemetics Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Antiemetics Consumption Forecast (2022-2028)

      • 13.6.3 Oman Antiemetics Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Antiemetics Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Antiemetics Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Antiemetics Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Antiemetics Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Antiemetics Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Antiemetics Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Antiemetics Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Antiemetics Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Antiemetics Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Antiemetics

    • Figure of Antiemetics Picture

    • Table Global Antiemetics Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Antiemetics Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 5-HT3 receptor antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Dopamine antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global NK1 receptor antagonist Consumption and Growth Rate (2017-2022)

    • Figure Global Antihistamines (H1 histamine receptor antagonists) Consumption and Growth Rate (2017-2022)

    • Figure Global Cannabinoids Consumption and Growth Rate (2017-2022)

    • Figure Global Benzodiazepines Consumption and Growth Rate (2017-2022)

    • Figure Global Anticholinergics Consumption and Growth Rate (2017-2022)

    • Figure Global Steroids Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Motion sickness Consumption and Growth Rate (2017-2022)

    • Figure Global Gastroenteritis Consumption and Growth Rate (2017-2022)

    • Figure Global General anesthetics Consumption and Growth Rate (2017-2022)

    • Figure Global Opioid analgesics Consumption and Growth Rate (2017-2022)

    • Figure Global Dizziness Consumption and Growth Rate (2017-2022)

    • Figure Global Pregnancy Consumption and Growth Rate (2017-2022)

    • Figure Global Food poisoning Consumption and Growth Rate (2017-2022)

    • Figure Global Emotional stress Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Antiemetics Consumption by Country (2017-2022)

    • Table North America Antiemetics Consumption by Country (2017-2022)

    • Figure United States Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Canada Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Mexico Antiemetics Consumption and Growth Rate (2017-2022)

    • Table Europe Antiemetics Consumption by Country (2017-2022)

    • Figure Germany Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure UK Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Spain Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Belgium Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure France Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Italy Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Denmark Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Finland Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Norway Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Sweden Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Poland Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Russia Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Turkey Antiemetics Consumption and Growth Rate (2017-2022)

    • Table APAC Antiemetics Consumption by Country (2017-2022)

    • Figure China Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Japan Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure India Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Thailand Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Singapore Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Philippines Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Antiemetics Consumption and Growth Rate (2017-2022)

    • Table South America Antiemetics Consumption by Country (2017-2022)

    • Figure Brazil Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Colombia Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Chile Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Argentina Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Peru Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Antiemetics Consumption and Growth Rate (2017-2022)

    • Table GCC Antiemetics Consumption by Country (2017-2022)

    • Figure Bahrain Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Oman Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Qatar Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Antiemetics Consumption and Growth Rate (2017-2022)

    • Table Africa Antiemetics Consumption by Country (2017-2022)

    • Figure Nigeria Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure South Africa Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Egypt Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure Algeria Antiemetics Consumption and Growth Rate (2017-2022)

    • Table Oceania Antiemetics Consumption by Country (2017-2022)

    • Figure Australia Antiemetics Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Antiemetics Consumption and Growth Rate (2017-2022)

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Antiemetics Main Business and Markets Served

    • Table GlaxoSmithKline Antiemetics Product Portfolio

    • Table Sanofi Aventis Company Details

    • Table Sanofi Aventis Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Aventis Antiemetics Main Business and Markets Served

    • Table Sanofi Aventis Antiemetics Product Portfolio

    • Table Astellas Company Details

    • Table Astellas Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Antiemetics Main Business and Markets Served

    • Table Astellas Antiemetics Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Antiemetics Main Business and Markets Served

    • Table Pfizer Antiemetics Product Portfolio

    • Table Merck Company Details

    • Table Merck Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Antiemetics Main Business and Markets Served

    • Table Merck Antiemetics Product Portfolio

    • Table Bristol Myers Squibb Company Details

    • Table Bristol Myers Squibb Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Antiemetics Main Business and Markets Served

    • Table Bristol Myers Squibb Antiemetics Product Portfolio

    • Table Eli Lilly Company Details

    • Table Eli Lilly Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Antiemetics Main Business and Markets Served

    • Table Eli Lilly Antiemetics Product Portfolio

    • Table Baxter Company Details

    • Table Baxter Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Baxter Antiemetics Main Business and Markets Served

    • Table Baxter Antiemetics Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Antiemetics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Antiemetics Main Business and Markets Served

    • Table Johnson & Johnson Antiemetics Product Portfolio

    • Figure Global 5-HT3 receptor antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dopamine antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK1 receptor antagonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antihistamines (H1 histamine receptor antagonists) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cannabinoids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Benzodiazepines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anticholinergics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Motion sickness Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global General anesthetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Opioid analgesics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dizziness Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pregnancy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Food poisoning Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Emotional stress Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antiemetics Consumption Forecast by Country (2022-2028)

    • Table North America Antiemetics Consumption Forecast by Country (2022-2028)

    • Figure United States Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antiemetics Consumption Forecast by Country (2022-2028)

    • Figure Germany Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Antiemetics Consumption Forecast by Country (2022-2028)

    • Figure China Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Antiemetics Consumption Forecast by Country (2022-2028)

    • Figure Brazil Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Antiemetics Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Antiemetics Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Antiemetics Consumption Forecast by Country (2022-2028)

    • Figure Australia Antiemetics Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Antiemetics Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.